Literature DB >> 8556495

Monokine-mediated increase in human immunodeficiency virus type 1 expression in chronically infected promonocyte- and T-cell-derived lines.

W Z Ho1, N Tomassini, R Cherukuri, G Shun-D, L Song, H R Lee, S D Douglas.   

Abstract

The ACH-2 cell clone derived from a human T-cell line and chronically infected with human immunodeficiency virus 1 (HIV-1) and the U1 cell clone derived from a human promonocyte cell line and also chronically infected with HIV-1 produce HIV-1 in a response to stimulation with monokine-enriched supernatants prepared from highly purified populations of peripheral blood-derived human monocytes. Monokine-mediated expression of HIV-1 in these cell lines resulted in augmented virus production reflected by increases in reverse transcriptase (RT) activity, production of p24 antigen, and synthesis of major viral proteins. Examination of the cells by electron microscopy revealed numerous HIV-1 virions in the cells treated with the supernatants. This stimulation of virus production by monokine-enriched supernatants resulted in approximately 100-fold increases in RT activity and p24 antigen expression in comparison with those in untreated U1 and ACH-2 cells. Absorption of monokine-enriched supernatants with rabbit anti-tumor necrosis factor alpha antibody removed most, but not all, of the induced HIV-1 RT activity and p24 antigen expression in U1 and ACH-2 cell lines, suggesting that tumor necrosis factor alpha in the monokine-enriched supernatants is a major factor in the induction of HIV-1 expression in these cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8556495      PMCID: PMC368326          DOI: 10.1128/cdli.1.5.517-525.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  30 in total

1.  Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate.

Authors:  T M Folks; J Justement; A Kinter; S Schnittman; J Orenstein; G Poli; A S Fauci
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

Review 2.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

Authors:  A S Fauci
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

Review 3.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

4.  Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

Authors:  T M Folks; J Justement; A Kinter; C A Dinarello; A S Fauci
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

5.  Purification of human monocytes on gelatin-coated surfaces.

Authors:  N F Hassan; D E Campbell; S D Douglas
Journal:  J Immunol Methods       Date:  1986-12-24       Impact factor: 2.303

Review 6.  The effect of cytokines and pharmacologic agents on chronic HIV infection.

Authors:  G Poli; A S Fauci
Journal:  AIDS Res Hum Retroviruses       Date:  1992-02       Impact factor: 2.205

Review 7.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

8.  Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome.

Authors:  J Lähdevirta; C P Maury; A M Teppo; H Repo
Journal:  Am J Med       Date:  1988-09       Impact factor: 4.965

9.  Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes.

Authors:  S K Burchett; W M Weaver; J A Westall; A Larsen; S Kronheim; C B Wilson
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

10.  In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.

Authors:  R L Willey; D H Smith; L A Lasky; T S Theodore; P L Earl; B Moss; D J Capon; M A Martin
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

View more
  3 in total

1.  Monocytes/macrophages in diagnosis and immunopathogenesis.

Authors:  S D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication.

Authors:  Tami Benton; Kevin Lynch; Benoit Dubé; David R Gettes; Nancy B Tustin; Jian Ping Lai; David S Metzger; Joshua Blume; Steven D Douglas; Dwight L Evans
Journal:  Psychosom Med       Date:  2010-10-14       Impact factor: 4.312

3.  Chemistry and Bioinformatics Considerations in Using Next-Generation Sequencing Technologies to Inferring HIV Proviral DNA Genome-Intactness.

Authors:  Guinevere Q Lee
Journal:  Viruses       Date:  2021-09-19       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.